Fund HoldingsACORN CAPITAL ADVISORS, LLC

Total Portfolio Value
$295.13M
Total Bought
$25.63M
Total Sold
$55.99M
Net Transaction
-$30.36M
Filing Period:
Securities
SharesValue ($K)
Q3 2025
Q4 2025
Change
Q3 2025
Q4 2025
Weight (%)
Change
TERNS PHARMACEUTICALS INC1,971,2641,746,264-225,00014,80470,54923.90%+55,745
UROGEN PHARMA LTD(URGN)1,259,7491,448,420+188,67125,13233,92211.49%+8,790
CYBIN INC734,3941,573,023+838,6294,31112,8744.36%+8,563
TREVI THERAPEUTICS INC(TRVI)2,144,8442,144,844019,62526,8539.10%+7,228
VERASTEM INC779,4981,469,153+689,6556,88311,3423.84%+4,459
ATHIRA PHARMA INC.0501,739+501,73903,7981.29%+3,798
PUMA BIOTECHNOLOGY INC4,131,2994,131,299021,93724,5818.33%+2,644
PROTARA THERAPEUTICS INC1,752,1151,752,11507,6229,3393.16%+1,717
CARDIF ONCOLOGY INC1,962,0841,962,08404,0425,5131.87%+1,472
CANDEL THERAPEUTICS INC2,580,5172,580,517013,16114,5804.94%+1,419
CG ONCOLOGY INC(CGON)1,131,5011,131,501045,57746,98015.92%+1,403
BICARA THERAPEUTICS643,382643,382010,15910,8283.67%+669
WHITEHAWK THERAPEUTICS INC1,139,3631,139,36302,1652,7570.93%+592
ONKURE THERAPEUTICS INC2,839,6742,839,67407,8098,2352.79%+426
ACRIVON THERAPEUTICS INC405,237405,23707339770.33%+243
X4 PHARMACEUTICALS INC273,349273,34909351,0930.37%+159
Q32 BIO INC.803,425493,425-310,0001,5911,6380.56%+47
JASPER THERAPEUTICS1,382,6401,786,492+403,8523,2913,2691.11%-21
VYNE THERAPEUTICS INC586,5721,425-585,14719910.00%-199
AURA BIOSCIENCES INC595,744595,74403,6823,2471.10%-435
BIOATLA INC4,835,1114,835,11103,3362,7560.93%-580
Page 1 of 1